文献速递神经头颈儿科影像MR

不对称性Meckel腔扩大:PHACES综合征的潜在影像标志物

Asymmetric Meckel Cave Enlargement: A Potential Marker of PHACES Syndrome.
PubMed 文献 · AJNR Am J Neuroradiol · 2017-04-13

本研究纳入85例因疑似PHACES综合征接受神经影像评估的患者,按最终临床诊断分为PHACES、可能PHACES和非PHACES三组,由不知最终诊断的阅片者评估单侧Meckel腔扩大。最终25例(29%)归为PHACES或可能PHACES,其中76%(19/25)存在不对称性Meckel腔扩大, definite PHACES患者中为82%(19/23),而60例非PHACES患者中均无此征象;19例有该征象的患者中7例(37%)的初始MR报告遗漏了符合PHACES的细微异常。作者认为不对称性Meckel腔扩大是PHACES患者的常见特征,可能作为新的影像标志物,提高对该征象的认识有可能提升PHACES的诊断准确性。

要点

  • 在疑似PHACES综合征患者中,不对称性Meckel腔扩大见于76%(19/25)的PHACES或可能PHACES患者。
  • definite PHACES患者中该征象出现率为82%(19/23),而60例非PHACES患者中均未出现。
  • 19例有该征象的患者中7例(37%)初始MR阅片遗漏了符合PHACES的细微异常。

核心结论

  • 不对称性Meckel腔扩大在PHACES综合征患者中常见,可能作为新的影像标志物,提高对该征象的认识有可能提升PHACES的诊断准确性。

研究设计与样本

  • 单中心回顾性研究,纳入85例因疑似PHACES综合征接受神经影像评估的患者,按最终临床诊断分为PHACES、可能PHACES和非PHACES三组,由对最终诊断不知情的阅片者评估MR图像上单侧Meckel腔扩大的有无。

关键影像表现/征象

  • 不对称性Meckel腔扩大表现为单侧Meckel腔扩大,在PHACES或可能PHACES患者中占76%(19/25),在definite PHACES患者中占82%(19/23),在非PHACES患者中占0%(0/60)。

诊断标准与关键数值

  • PHACES综合征的最终临床分类依据共识指南;不对称性Meckel腔扩大在PHACES或可能PHACES患者中的出现率为76%(19/25),在definite PHACES患者中为82%(19/23),在非PHACES患者中为0%(0/60)。

临床应用与阅片要点

  • 在疑似PHACES综合征患者的MR阅片中,应注意评估是否存在单侧Meckel腔扩大,该征象在PHACES患者中常见而在非PHACES患者中未见。
  • 19例有不对称性Meckel腔扩大的患者中7例(37%)的初始MR报告遗漏了符合PHACES的细微异常,提示阅片时需结合该征象仔细排查相关异常。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

BACKGROUND AND PURPOSE: PHACES syndrome is a complex of morphologic abnormalities of unknown cause and includes posterior fossa abnormalities; head and neck infantile hemangiomas; arterial, cardiac, and eye anomalies; and sternal or abdominal wall defects. Accurate identification of the syndrome is important for optimal treatment. The purpose of this study was to investigate the incidence of asymmetric Meckel cave enlargement, a potential novel imaging marker, in a population of patients referred for evaluation of possible PHACES syndrome.

MATERIALS AND METHODS: Eighty-five patients referred for neuroimaging evaluation of possible PHACES syndrome were identified and stratified on the basis of their ultimate clinical PHACES diagnosis categorization into PHACES, possible PHACES, or not PHACES. MR imaging studies were subsequently reviewed for the presence or absence of unilateral Meckel cave enlargement, with the reviewer blinded to the ultimate PHACES syndrome categorization.

RESULTS: Twenty-five of 85 patients (29%) were ultimately categorized as having PHACES or possible PHACES according to consensus guidelines. Asymmetric Meckel cave enlargement was present in 76% (19/25) of these patients and in 82% (19/23) of only those patients with definite PHACES. This finding was present in none of the 60 patients determined not to have PHACES syndrome. In 7/19 patients (37%) with this finding, subtle MR imaging abnormalities consistent with PHACES were missed on the initial MR imaging interpretation.

CONCLUSIONS: Asymmetric Meckel cave enlargement was a common feature of patients with PHACES in our cohort and may serve as a novel imaging marker. Increased awareness of this imaging feature has the potential to increase the diagnostic accuracy of PHACES.

来源:AJNR Am J Neuroradiol,查看原文。版权归原作者所有。

引用

  1. Wright JN, Wycoco V. Asymmetric Meckel Cave Enlargement: A Potential Marker of PHACES Syndrome. AJNR Am J Neuroradiol. 2017. PMID: 28408631. doi:10.3174/ajnr.A5140

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。